Acquisition synergy Applied Immunology was acquired by Precision Medicine Group, signaling potential cross-sell opportunities for PMG’s broader contract research, regulatory, and clinical capabilities to complement Applied Immunology’s immune profiling services.

Niche immunology focus Specialized immune profiling and regulatory strategy for biologics, vaccines, and diagnostics; potential for upsell into larger biotech and pharma client base seeking integrated immune monitoring with regulatory support.

Small team footprint Small employee count (2-10) and SF Bay Area location suggest flexibility and ability to scale with partner networks; ideal for pilot projects or pilot expansion with larger Precision Medicine Group accounts.

Revenue band Annual revenue in the 1–10 million range indicates a defensible niche player that can be positioned as a gateway CRO for mid-stage programs or as a specialized lab services tier within PMG’s portfolio.

Digital presence gap Prevalent web tech stack and modest public visibility imply room for improved marketing and lead generation; opportunities to leverage PMG’s marketing and sales engine to drive inbound interest and multi-service deals.